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Abstract- 
 
Diabetes mellitus is one of the most prevalent diseases found in the world population. In 
2012, according to the WHO report, 1.5 million people died due to diabetic related 
complications. Type 2 diabetes is a progressive disease. The currently prescribed medication 
lacks the specificity for targeting particular pathways or molecules involved in the 
complications. The appropriate understanding of the mechanisms responsible for the diabetes 
mellitus and its related complications can pave the way to the discovery of the target specific 
drugs for effective treatment. The current project makes a comprehensive study to get an 
insight into the probable mechanisms involved and the ways to counteract them. The study 
specifically centers around in vitro induction of BSA glycation and its inhibition, exploration 
of the effect of extracellular and the intracellular AGEs on the macrophages, protein 
glycation analysis and inhibition in diabetic serum. The in vitro glycation model using BSA 
confirmed the formation of the both fluorescent and non fluorescent advanced glycation end 
products (AGEs) in the hyperglycaemic condition. The amount of the AGEs formed 
increased with the duration of exposure to the hyperglycaemic condition as reflected by 
increased fluorescent intensity. The oxidative stress induced by hyperglycaemic condition 
was validated and quantified by NBT assay and H2DCFDA assay. Moreover, the ROS 
generation in macrophages was increased with addition of extracellular AGEs in the medium. 
The reduction in the cell viability as a consequence of high ROS production and the presence 
of the extracellular AGEs was confirmed by MTT assay. During inhibitor study, ascorbic 
acid exhibited pro-oxidant activity upon adding to the diabetic serum that makes the 
therapeutic use of ascorbic acid alone debatable unless otherwise verified further. At the same 
time, GSH and EDTA act as anti-oxidants in macrophages (hence, probably reduced the 
AGEs formation). In silico docking study was conducted to understand the mechanism of 
inhibition. The binding affinity of EDTA for BSA was significantly more compared to 
glucose that didn’t reduce much to glycated BSA. This concludes that EDTA can prevent 
glycation non-competitively and may also halt the progress of glycation of the protein.  The 
results were a step ahead in exploring the novel molecules for inhibiting the protein glycation 
in T2DM. For a more conclusive finding, a metacentric study involving more number of 
diabetic patients is needed. 
Key words- Advanced glycation end products (AGEs), reactive oxygen species (ROS), 
EDTA, bovine serum albumin (BSA). 
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Chapter 1 
INTRODUCTION 
Diabetes mellitus is a metabolic disorder in which due to lack of insulin or the body cannot 
utilize insulin function, leads to high blood glucose level over a prolonged period. This high 
blood glucose alters the normal body function by altering many pathways. The symptoms of 
high blood sugar are frequent urination, increased thrust and hunger. The acute and chronic 
effects due to diabetes include diabetic ketoacidosis, nonketotic hyperosmolar coma and heart 
disease, stroke, chronic kidney failure, foot ulcers, and damage to the eyes respectively. The 
types of diabetes mellitus are – 
a. Type 1 diabetes, also called as insulin dependent diabetes mellitus (IDDM)-it is 
characterized by a lack of insulin production. Without daily administration of insulin, 
type 1 diabetes is rapidly fatal. The development of IDDM is due to several factors 
such as autoimmune, genetic, and environmental factors. 
b. Type 2 diabetes, also called as non insulin dependent diabetes mellitus (NIDDM) 
results from the body’s ineffective use of insulin. About 90% of people with diabetes 
around the world have type 2 diabetes. The factors responsible for occurrence of 
NIDDM are older age, obesity, and family history of diabetes, prior history of 
gestational diabetes, impaired glucose tolerance, physical inactivity, and race. 
Regardless of oral treatments or insulin injections almost half of the patients with either type 
of diabetes develop late complications of neuropathy, retinopathy, nephropathy, and 
cardiomyopathy. The mechanisms involved in chronic complication of diabetes are under 
intensive research. The researchers have proposed many theories to establish relation between 
high glucose level and its long term implications. 
Neuropathy is a generalized term frequently used by physicians to indicate defect in sensory 
perception (attenuated/exaggerated/altered sensation to external stimulus), abnormal visceral 
regulatory activities and/or partial or complete loss of motor activities of the limbs. The cause 
of neuropathy is partial (reversible) damage to neurons from primary or secondary causes. 
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Table 1: Chronic complications associated with diabetic neuropathy- 
Health 
complications 
from diabetes 
Affected 
region 
Occurrence symptoms 
 
Diabetic 
retinopathy 
eye Affects 
10% 
people 
with 
diabetes 
 Spots or dark strings floating in your vision 
(floaters) 
 Blurred vision, Fluctuating vision, and impaired 
colour vision. 
  Vision loss. 
 
Diabetic 
neuropathy 
Nerves, 
blood 
vessels 
Affects 
50% 
people 
with 
diabetes 
Tingling, pain, numbness, or weakness in the feet 
and hands. 
Diabetic 
nephropathy 
kidney Affects 10-
20% 
people 
with 
diabetes 
 Albumin or protein in the urine, High blood 
pressure. 
 Ankle and leg swelling, leg cramps. 
 High levels of blood urea nitrogen (BUN) 
Neuropathy that arises from sustained hyperglycaemia in diabetic patients (both IDDM and 
NIDDM) is categorized under Diabetic neuropathy. The medical term for nerve damage, so 
type of nerve damage due to diabetics is diabetic neuropathy. The nerve most often damaged 
is of hands and legs. 
People with diabetes are prone to develop nerve problem at any time but chances are highest 
among with uncontrolled glucose level during long term diabetes.  The nerves to the feet are 
the longest in the body and are the ones most often affected by neuropathy. 
Nerve damage is due to a combination of factors: 
 metabolic factors, such as high blood glucose, long duration of diabetes, abnormal blood 
fat levels, and low levels of insulin 
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 neurovascular factors, leading to damage to the blood vessels that carry oxygen and 
nutrients to nerves 
 autoimmune factors that cause inflammation in nerves 
 mechanical injury to nerves, such as carpal tunnel syndrome 
 inherited traits that increase susceptibility to nerve disease 
 lifestyle factors, such as smoking or alcohol use 
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Chapter 2 
LITERATURE REVIEW 
Various theories have been proposed to explain patho-physiology of diabetic neuropathy. The 
most popular among them are the polyol pathway theory, the vascular theory and 
glycosylation end product theory (11). The major complications of diabetes are peripheral 
and autonomic neuropathy, micro vascular and macro vascular diseases (11). The frequency 
of occurrence of peripheral neuropathy is higher compare to autonomic neuropathy as 
glucose uptake in peripheral nerves is not dependent on insulin (1). The structural and 
functional abnormalities induced in the diabetic nerve are neuronal ischemia and infractions, 
endothelial cell hyperplasia, demyelination, axonal degeneration of peripheral nerves, 
reduced nerve conduction and blood flow (7). The main reason behind demyelination is -due 
to high glucose myelin is glycated and as a consequence macrophages are activated to secrete 
protease causing demyelination (7). 
The first hypothesis linking hyperglycaemia and nerve dysfunction is polyol (sorbitol) 
pathway theory. The main enzyme of the pathway involved in pathophysiology is aldose 
reductase (14). 
Table 2: Comparison of pathways involved in normal and pathological condition- 
Normal condition- Pathological condition- 
normal blood glucose level elevated blood glucose 
Hexokinase not saturated Hexokinase saturated(activates aldose 
reductase) 
Most glucose converted to glucose-6 
phosphate 
Glucose diverted to polyol pathway 
No or trace amount of sorbitol detected Appreciable amount of sorbitol formed  
Major pathway-glycolysis 
Minor pathway-polyol pathway 
Major pathway-sorbitol pathway 
Minor pathway-glycolysis 
 
The accumulation of sorbitol leads to tissue toxicity as it is a non charged intracellular 
osmolytes. The other pathological changes induced are depletion of cytoplasmic osmolytes 
such as myoinositol, increased aldose reductase activity and interaction with p38 MAP kinase 
(14, 15). 
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As a consequence of decreased myoinositol level the level of phosphoinositide is decreased 
which directly cause reduction in Na/K ATPase activity (9). Activation of aldose reductase 
depletes its cofactor NADPH. The decreased NADPH level affects many pathways- first 
there is no formation of reduced glutathione, leads to free radical formation. Secondly 
NADPH acts as a cofactor for nitric oxide synthase (NOS), thus no NO generation inhibits 
vascular relaxation causing chronic ischemia (14). 
The chronic intracellular hyperglycaemia leads to generation of family of glycation agents 
known as advanced glycosylation end products (AGE) (2, 7).The various pathways involved 
in synthesis are (13)- 
 Protein glycation via formation of stable intermediates such as amadori products and 
dicarbonyl intermediates like 3DG (3-deoxyglucosomes). 
 Auto oxidative glycation- leads to formation of ketoimine in the presence of transition 
metal and enediol radical.  
Interaction of AGE with its receptor on macrophages increases oxidative stress activating 
NFκB pathway which leads to formation of various inflammatory molecules. The various in 
vitro effect of AGE formation observed are- 
 Modification of P0 protein with AGE causes demyelination of nerve fibers(1) 
 Induced cell death of neuronal and Schwann cells (12) 
 Reduced expression of NO synthase thus reduced nerve blood flow.(3) 
 The oxidative stress induced by AGE enhances glycation of Na/K ATPase, reducing 
its activity.(4) 
Nitric oxide is nontoxic in biological system as it is rapidly converted to nitrate by reaction 
with oxy-haemoglobin in RBC(15).In pathological condition both superoxide and NO are 
synthesized a few cell diameter of each other thus they combine spontaneously to form 
peroxynitrite.Peroxynitrite modifies various enzymes involved in mitochondrial respiratory 
chain. It also induces DNA and lipid damage.DNA damage activates PARP (poly-ADP-
ribose Polymerase) enzyme .The substrate for PARP is NAD thus lower intracellular 
concentration of NAD affect pathways for ATP generation.ATP depletion leads to cell death. 
(16) 
To check relation between iNOS mediated peroxynitrite generation studies were carried out 
on animal models. The mice knocked out for the iNOS gene was protected against chemically 
induced diabetes. In cardiomyopathy the increased expression of iNOS leads to increased 
production of nitric oxide and superoxide forming peroxynitrite.  The peroxynitrite oxidize 
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zinc thiolate complex of eNOS, forming uncoupled eNOS which generates more 
peroxynitrite (17). 
As shown in figure 1 – there are two pathways involved in peroxynitrite generation, one with 
interaction of hydrogen peroxide and hydroxyl free radicals with nitrite to form peroxynitrite 
and other through increase in iNOS expression during inflammation. The increased 
expression of iNOS leads to formation of more peroxynitrite.  
Peroxynitrite activates Caspase, induces necrosis thus causing cell death (17).The long term 
hyperglycaemia causes downstream metabolic cascade of polyol pathway hyperactivity, 
advanced glycation end products (AGE)/receptor of AGE reaction (RAGE), increased 
reactive oxygen species (ROS). They comprise both endoneurial micro vessels and neural 
tissues themselves through activation of poly-ADP-ribose polymerase (PARP), alteration of 
PKC and increase in mitogen activated protein kinase (MAPK), as well as activation of 
nuclear factor (NF-ΚB) resulting in functional and structural changes of peripheral 
neuropathy. Metabolic aberrations in the nerve elicit pro-inflammatory reactions, inducing 
release of cytokines, suppression of neutrophiles and migration of macrophages and promote 
development of neuropathy. (18) 
 
Figure 1 - Electron transport chain (22) 
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The mitochondria are the major source of superoxide production inside the cell. Under 
physiological condition the metabolized glucose through citric acid cycle generates electron 
donor NADH and FADH2 respectively. The NADH donates electron to complex1 and 
FADH2 to the complex 2(30). The mobile electro carrier coenzyme Q carries these electrons 
from both the complexes to the final electron acceptor i.e. molecular oxygen (25). Some 
energy of transported electrons is utilized to pump protons across the mitochondrial 
membrane. The voltage gradient generated due to proton pumping across the mitochondrial 
membrane leads to the formation of the ATP. (27) 
The high levels of glucose in diabetic conditions generate more electron donors. Due to the 
electron transport across the four complexes, the established voltage gradient across the 
mitochondrial membrane increases until the threshold level is reached.  After reaching the 
critical threshold value the complex 3 electron transport is halted. This causes accumulation 
of the electrons at coenzyme Q (28). At a time coenzyme Q donates single electron to 
molecular oxygen thus generating superoxides. Thus one of the initial ROS formed inside the 
cell is superoxide. (30) 
The dysfunctional mitochondrion due to redox imbalance inside the cell generates 
superoxides which have been involved in the development of the diabetic complications. The 
two major sites have been proposed within the mitochondria, the complex 1 and the Q cycle 
where electron leakage generates superoxide. Many in vitro studies have postulated that the 
early disintegration of the mitochondrial membrane potential leads to excessive production of 
O2
-
. (35) 
The three damaging pathways are initiated by the hyperglycaemia induced superoxide 
production. The three damaging pathways are activated due to inhibition of GADPH.  All the 
glycolytic intermediates above the GADPH utilization step are increased in the concentration. 
This leads to activation of the following pathways (38)- 
a. AGE pathway activation- glyceraldehydes 3 phosphate forms the AGE precursor 
methylglyoxal. 
b. Classical PKC pathway activation- the diacylglycerol of the PKC pathway is formed 
from the glyceraldehydes 3 phosphate. 
c. The increased level of the glucose increases flux through polyol pathway 
2.1 AGE formation – 
 
The 90% cases reported of diabetes are of type2 diabetes. The type2 diabetic conditions are 
either due to resistance to the produced insulin or due to less production of the insulin by the 
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body. The people suffering from diabetes are at high risk of nephropathy, neuropathy, 
cardiomyopathy, retinopathy and many such complications (35). The microvascular diseases 
comprise of retinopathy, nephropathy and peripheral neuropathy and the macro vascular 
complications mainly include cardiomyopathy (36). Three main theories have been proposed 
to describe pathophysiology of diabetes and its related complications. The three proposed 
theories are the polyol pathway theory, the micro and macro vascular theory and 
glycosylation end product theory. The unregulated glucose concentration induces increased 
influx of glucose through these pathways. All these mechanisms have been interlinked to 
culminate the redox imbalance inside the body. (38) 
Redox imbalance leads to magnificent reactive oxygen species generation by the 
mitochondrion which in turn again amplifies the functionality of all pathological pathways 
involved. This viscous cycle of augmentation leads to inevitable consequences of several 
complications. (40) 
2.2 Polyol pathway theory – 
 
This was the first pathway which linked hyperglycaemia with nerve degeneration. Under 
diabetic conditions  
 
Figure 2- Polyol pathway (14) 
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Hexokinase is saturated due to high glucose concentration which activates aldose reductase. 
The activated aldose reductase initiates polyol pathway synthesizing sorbitol (44). The 
accumulation of the sorbitol inside the tissues causes exhaustion of other osmolytes like 
myoinositol. The decreased myoinositol level has direct implication of impaired Na/K 
ATPase activity (48).  The concentration of the cofactor NADPH required for the activation 
of the aldose reductase is also decreased. The decreased level of NADPH leads to reactive 
oxygen species generation as there is no formation of reduced glutathione (49).  
Elevated level of fructose in polyol pathway generates advanced glycation end products. The 
oxidative stress because of osmotic imbalance and increased oxidant production causes 
inflammation and programmed cell death.  
2.3 Glycosylation end product theory  
 
The non enzymatic glycation of proteins forms fluorescent and non fluorescent advanced 
glycation end products. The several proteins which are glycated due to hyperglycemic 
conditions are albumin, fibrinogen, collagen and immunoglobulin. (49)   
The in vitro protein glycation has been established by subjecting diverse protein model to 
hyperglycaemic conditions. The fluorescent intensity peak at 440nm confirms formation of 
fluorescent AGEs such as pentosidine and cross line with bovine serum albumin.(56) The 
formation of non fluorescent AGEs like praline, carboxymethyllysine etc. with bovine serum 
albumin confirmed by measuring m/z ratio of obtained peptide using electron spray 
ionization mass spectrometry (ESI-MS). The AGE formation leads to activation of several 
pathological pathways 
The one of the major pathway for diabetic complications is formation of advanced glycation 
end products. The non-enzymatic glycation of the plasma protein such as globulin, fibrinogen 
and albumin produces several damaging effects like (54)- 
 Generation of oxygen free radicals 
 Defects in immune system regulation 
 Platelet activation and altered drug binding capacity of the glycated plasma proteins 
10 
 
 
Figure 3- The pathways involved in the formation of advanced glycation end products (59). 
The main pathways involved in the formation of the advanced glycation end products are 
(59)- 
 Auto-oxidative pathway- In the presence of free radicals the glucose undergo 
oxidation to form advanced glycation end products. Thus ROS generation initiates 
advanced glycation end product formation. 
 Amadori rearrangements- The non enzymatic interaction of the amino acid with the 
carbonyl group of the reducing sugar generates a reversible product known as Schiff 
base. The Schiff base further undergoes process of cyclization to form more stable 
amadori products. The amadori products form advanced glycation end product by two 
ways either oxidative cleavage or non- oxidative cleavage. In oxidative cleavage the 
intermediates formed undergo process of autoxidation and rearrangements to form 
carboxymethyl-lysine. The non oxidative cleavage of amadori products form 3-
deoxyglucosane , which further reacts with amino acids to form crosslink AGEs such 
as , pentosidine, or imidazolone. 
 
 Namiki pathway- Alpha dicarbonyl are the main precursor in the AGE formation. In 
this pathway Schiff base forms glyoxal precursor for AGE formation. 
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 Wolff pathway- Auto-oxidation of the glucose accelerates the formation of the alpha 
dicarbonyl precursor which enhances AGE formation. 
 Glycolytic pathway- the intermediates of the glycolysis such as glucose-6-phosphate, 
glyceraldehydes-3-phosphate and dihydroxyacetone phosphate generates alpha 
dicarbonyl precursor forming advanced glycation end products. 
 Lipid peroxidation- The reactive oxygen species causes lipid peroxidation. Lipid 
peroxidation generates dicarbonyl precursors for the formation of the advanced 
glycation end products. 
The glycation of the human serum albumin alters the structural and functional properties of 
this plasma protein in many ways (60)- 
 Becomes less efficient for transporting long chain fatty acid  
 Generation of intracellular reactive species. 
The important factors affecting the non-enzymatic glycation of proteins both in vivo and in 
vitro are (55)- 
i. Glucose concentration-the high the glucose concentration the more the formation of 
advanced glycation end products. 
ii. Duration of exposure to the high concentration of the glucose- the longer the exposure 
time to hyperglycemic condition , high the concentration of AGEs formed. 
2.4 Classification of AGEs- 
 
The three main groups in which advanced glycation end products has been classified are 
based on the structural properties. 
Table 2- Types of AGEs formed- 
Name of AGEs Fluorescent-cross 
linking AGEs 
Non-fluorescent 
cross-linking AGEs 
Non-cross-linking 
AGEs 
Examples Pentosidine 
 
crossline 
Imidazolium dilysine 
cross-links 
Alkylformyl glycosyl 
pyrrole cross-links 
Arginine-lysine 
imidazole cross-links  
 
Pyrraline 
 
N-carboxymethyl 
lysine(CML) 
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2.5 AGE – RAGE interaction- 
The receptors for AGEs are expressed on many cells in vivo for many cellular metabolic 
activities. The cells expressing these receptors are macrophages, endothelial cells, astrocytes 
and smooth muscle cells. In diabetic conditions there is both enhanced formation of the 
advanced glycation end products and also increased expression of the RAGE. (42) 
AGE-RAGE interaction increases NFκB expression which transduces pro-inflammatory, and 
pro-apoptotic signals inside the cell. Formation of NFκB also leads to increased expression of 
the RAGE on the cell surface. The interaction has also been linked to activation of NADPH 
oxidase and mitochondrial membrane depolarization thus inducing ROS generation in the 
cell. (48) 
Apart from the RAGE receptor, AGE also interacts with the several other receptors expressed 
on the surface of the cells. These receptors are lactoferrin, scavenger receptor type1 and 2, 
CD36, oligosaccharyl trasferase -48, 80 K-H phosphoprotein. (59) 
 
Figure 4- The activation of NADPH oxidase with CD36 cell surface receptor on the 
macrophages. (58) 
The CD36 receptor expressed on the macrophages is a multiligand receptor. One of the 
interaction pathways of this receptor with oxidized low density lipoprotein in the 
macrophages activates NADPH oxidase. (54) The activation of the NADPH oxidase leads to 
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superoxide production inside the cell. The AGE not only leads to ROS generation but also 
structural changes are induced in the proteins leading to the impaired function. The 
mitochondrial dysfunction leading to the oxidative stress is as a consequence of the non-
oxidative dicarbonyl glycation. The enhanced ROS generation under the hyperglycaemic 
condition due to advanced glycation end product formation cast towards the activation of the 
pathways which actuate NADPH oxidase and mitochondrial superoxide generation. The 
structural changes in the mitochondrial membrane proteins initiates’ dicarbonyl intermediate 
formation actuating intracellular advanced glycation end product formation which causes loss 
of mitochondrial membrane potential forming ROS.  
Thus both intracellular and extracellular advanced glycation end products induce cells to 
generate more ROS in the hyperglycaemic conditions. (56) 
The activation of NADPH oxidase generates superoxide, the enzymatic defence against 
superoxide is activated, and in this case superoxide dismutase (SOD) reduces superoxide to 
hydrogen peroxide, which leads to increased expression of eNOS. The nitric oxide 
synthesized from eNOS combines with the generated superoxides to form peroxynitrite. The 
oxidation of the essential co-factors for eNOS by the peroxynitrite forms uncoupled e NOS 
which only generates superoxide without formation of nitric oxide. As a consequence 
amplification of the intracellular ROS generation occurs inside the cell.  
2.6 Role of glutathione – 
 
Glutathione is synthesized in the body form the amino acids L-cysteine, L-glutamic acid, and 
glycine. It is regarded as the mother of all the anti-oxidants (51). Glutathione relieves cell 
from the oxidative stress as glutathione the reduced form accepts electrons from the free 
radicals getting oxidized to form oxidized glutathione (53). The reduced form of the 
glutathione in the cell is maintained by the cofactor NADPH which donates electron to the 
oxidized glutathione to replenish the antioxidant glutathione. The alteration in the 
concentration of the NADPH cofactor in the cell correlates to the oxidative stress as the 
reduced glutathione is not recycled to react with the superoxides.  
2.7 Role of vitamin c- 
 
Vitamin c has both antioxidant and pro-oxidant activity. The concentration of the vitamin c 
used is the deciding factor whether it acts as anti-oxidant or pro-oxidant. The interaction of 
the vitamin c with the metal ions generates hydroxyl free radical through the fenton pathway. 
In chronic inflammation the concentration of the unbound iron increases (55). The free iron is 
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tremendously toxic to the cells. In the fenton reaction ascorbic acid recycle the ferrous iron 
forming dehydro ascorbate (42). The ferrous iron reacts with the oxygen generating 
superoxides. The reaction has been linked to the oxidation of proteins, membrane lipids and 
also occurs in the presence of the biological reducing agent such as ascorbic acid. The anti-
oxidant activity of the vitamin c is determined by the concentration of the free metal ions in 
the body and the amount of vitamin c used as high concentration usually has pro-oxidant 
effect. Thus catalytic metal ions such as iron and ascorbic acid cocktail have damaging effect 
on the cells (58). 
 
Figure 5- Pro-oxidant activity of the ascorbic acid 
2.8 Types of free radicals formed in the body- 
 
The balance between the free radicals generated in the body and the enzymatic and non- 
enzymatic anti-oxidant systems activity helps in maintaining the normal homeostasis of the 
body (59). The increase in the free radical formation and the decreased activity of the 
available anti-oxidant system is responsible for the generation of the oxidative stress. In the 
physiological conditions the generated superoxide from the complex 3 of the mitochondria 
are reduced to hydrogen peroxide by superoxide dismutase. In pathological conditions the 
impaired functionality of complex 1 leads to excessive ROS production from the 
mitochondria and the subsequent reduction in the activity of the free radical scavengers 
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enhances the level of ROS in the cell causing oxidation of the proteins, lipids and ultimately 
cell death (54). The mitochondrion is the main source for the intracellular ROS generation. 
NADPH oxidase is the source for the extracellular ROS in the phagocytic cells like 
macrophages. Thus both extracellular and intracellular ROS is responsible for diabetic related 
complications. (60) 
Objectives 
In vitro glycation studies with bovine serum albumin (BSA)- 
 To  prove in vitro glycation of bovine serum albumin and to identify  the  different 
types of AGEs formed and to establish structural change due to glycation  
To investigate effect of high glucose on macrophages - 
• Checking viability  
• To check ROS generation and the types of ROS produced  
• To investigate intracellular AGEs formation  
To check AGEs formation in the diabetic serum 
To carry out inhibitory studies with the in vitro and diabetic serum 
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Chapter3 
MATERIALS AND METHODS- 
3.1 Advanced glycation end product formation with Bovine serum albumin - 
3.1.1 Materials required – Bovine serum albumin (BSA), phosphate buffer saline, glucose, 
autoclaved water 
3.1.2   procedure- 
2mg/ml of BSA used for making 3 solutions with different glucose concentration.BSA, PBS, 
water, glucose was mixed in the ratio of 2:5:2:1.The glucose concentration added in the range 
of 1mg/ml and 3mg/ml.The prepared samples were incubated at 37ºc for 1week.The AGE 
formation was confirmed by measuring fluorescence intensity at excitation and emission 
wavelength of 370nmand 440 nm respectively. 
3.2 Circular dichroism analysis of the glycated BSA- 
 
3.2.1- Materials required- BSA, buffer, autoclaved water, CD instrument 
3.2.2 Procedure- 
1mg of the bovine serum albumin was dissolved in the 5ml of the 1:1 ratio of the phosphate 
buffer saline and autoclaved water. Three samples containing BSA, BSA with 1mg/ml of the 
glucose and BSA with 3mg/ml of the glucose respectively were prepared in the 5ml of the 
stated solution. After one week of the incubation at 37ºc the samples were scanned in the 190 
to 260 nm range for the detection of the secondary structures present in the protein. 
3.3Detection of non-fluorescent AGEs using ESI-MS- 
 
3.3.1 Materials required- HPLC Grade water, bovine serum albumin, d-glucose, 45nm filter 
3.3.2 Procedure- 
The samples were prepared by dissolving 1mg of the protein in 10 ml of the HPLC grade 
water. As the concentration of the protein used should be less than 50 ppm. The two samples 
were prepared, one with only BSA and the other with BSA + 3mg/ml of the glucose. The 
prepared samples were incubated for the week at 37ºc. Before analysis the samples were 
syringe filtered. The m/z ratios of the peptides were obtained. 
3.4 Inhibitory studies for the formed AGEs using fluorometer- 
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3.4.1 Materials required- BSA, disodium EDTA, glucose, glutathione, vitamin c, PBS, 
autoclaved water, incubator, fluorometer 
3.4.2 Procedure- 
The 1.5 mg of the di-sodium EDTA was added to the samples prepared with the BSA and 
glucose. 2.5 mg of the glutathione and vitamin c each added to the samples with the BSA and 
glucose. The combination of these inhibitors was also used. After one week of the incubation 
with inhibitors the sample were analyzed in the emission spectra of 440nm with fluoromax 
fluorometer. 
3.5 Culturing macrophages under high glucose condition- 
 
3.5.1 Materials required- RAW 264.7, DMEM low glucose media, syringe filtered glucose, 
antibiotic, fetal bovine serum, 6-well plate 
3.5.2 Procedure- 
Four complete media were prepared containing 2mg/ml; 3mg/ml and 4mg/ml glucose 
concentration respectively and equimolar concentration of the mannitol.Cells were scrapped 
and pelleted down to culture in 6 well plates containing 2ml of media with different 
concentration of glucose. The cultured cells incubated at 37ºc for further analysis. 
3.6 NBT assay for measuring superoxide production- 
 
3.6.1Materials required- freshly prepared NBT dye, DMSO, cells seeded in 96 wells plate, 96 
well plate spectrophotometer 
3.6.2 Procedure- 
The cells  seeded in the 96 well plates on 8
th
 and 16
th
 day of incubation period were analyzed 
for superoxide production.5μl of NBT dye added to 50μl media containing cells and 
incubated at 37ºc for 2hrs.After incubation the complete media was remove and 140μl of 
DMSO was added. After 5 minutes of incubation absorbance measured at 620nm.  
3.7 MTT assay for cell viability- 
3.7.1 Materials required- MTT dye, DMSO, cells seeded in 96 wells plate, 96 well plate 
spectrophotometer 
3.7.2 Procedure- 
10μl MTT dye was added to 100μl of media containing cells with different glucose 
concentration at 8
th
 and 16
th
 day of incubation. The samples were incubated for 4 hrs at 
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37ºc.After incubation the whole media was removed and 100μl of DMSO was added. After 
15 minutes of incubation absorbance reading at 595 nm was measured. 
3.8 assay for measuring ROS production- 
 
3.8.1 Materials required- freshly prepared H2DCFDA dye, 96 well plates, macrophages, 96 
well plate spectrophotometer 
3.8.2 procedure- 
100μl of media containing cells were poured in 96 well culture plate After 24 hrs incubation 
media was removed.30μl of dye was added to each well. Cells were incubated for 30 minutes 
and fluorescent intensity measured at 523nm. 
3.9 The in vitro glycation of the human serum albumin - 
 
3.9.1 Materials required- purified human serum albumin, d-glucose, phosphate buffer saline, 
autoclaved water, and incubator. 
3.9.2 Procedure-  
The 2mg/ml of the protein concentration was used for the preparation of the samples with the 
different glucose concentration. The 2mg/ml, 3mg/ml and 4mg/ml of the glucose 
concentration was dissolved in 1:1 ratio of the PBS and water containing 2mg/ml of the 
protein in each sample. The prepared samples were incubated at 37ºc for the one week. The 
formation of the fluorescent AGEs confirmed by the visualization of the sample at excitation 
of 370nm and emission range of 440-470nm in confocal microscope. 
3.10 To visualize the formed AGEs with the confocal microscopy- 
 
3.10.1 Material required- the one week glycated sample of the human serum albumin, 
fixtures, confocal microscope. 
3.10.2 procedure- 
The fixtures were prepared. Before the analysis the samples were poured in the fixtures. The 
fluorescent intensity was measured in the emission range of the 440-470 nm.  
3.11 H2DCFDA – dye for the visualization of the ROS- 
3.11.1 Material required- formed AGEs with in vitro model, cells cultured in high glucose, 
H2DCFDA dye, fluorometer 
3.11.2 Procedure- 
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The 20 μl of the one week incubated human serum albumin with 2mg/ml, 3mg/ml and 4 
mg/ml of the glucose concentration respectively was added to the macrophages grown in the 
2mg/ml, 3 mg/ml and 4mg/ml of the glucose concentration in the media. After one week of 
incubation with the advanced glycation end products the cells were scrapped and centrifuged. 
The obtained pellet was resuspended in the1 ml of the fresh media. The 2*10^5 cells/ml were 
taken from all the samples and 30μl of the dye was added to the each sample. After 
30minutes of the incubation the fluorescent intensity was observed in 523nm emission range. 
The cells cultured in 2mg/ml and 4 mg/ml concentration of the glucose were from their 
2*10^5 cells/ml were taken and 1.5 mg of the EDTA and 2.5mg of the glutathione was 
added. After 24 hrs of the incubation in the co2 incubator, the 30μl of the dye was added to 
each sample and the fluorescent intensity was measured in the emission range of 523nm. 
3.12 Isolation of serum from diabetic blood- 
3.12.1 Materials required- serum selection tube containing ficoll, diabetic blood, centrifuge 
3.12.2 Procedure- 
The diabetic blood was collected without adding anticoagulant in the serum selection tube. 
The blood was kept at room temperature for half an hour .The collected blood was  
centrifuged at  1000*g for 10 minutes .Above ficoll layer a distinct layer of serum was 
collected in sterile tube and stored at 4ºc for further analysis. 
3.13 Inhibition of AGE in diabetic serum using EDTA- 
3.13.1Materials required- isolated serum, Ethylenediaminetetraacetic acid (EDTA), glucose, 
autoclaved distilled water, phosphate buffer saline (PBS), fluorometer 
3.13.2 Procedure- 
1.5 mg/ml EDTA was added to the 5ml solution containing PBS and autoclaved water in 1:1 
ratio. The fluorescence intensity was measured to confirm inhibition at excitation wavelength 
of the 370nm and emission wavelength 0f 440nm. 
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Chapter4 
RESULTS AND DISCUSSIONS 
 
4.1 In vitro advanced glycation end product formation (AGE) formation in 
bovine serum albumin (BSA)- 
The fluorescent advanced glycation end products (AGEs) formation was confirmed by the 
emission peak at the 440 nm. 
In the Millard reaction the glucose carbohydrate group reacts with the amine group of the 
protein forming Schiff base which rearranges to form amadori products, these unstable 
amadori products leads to formation of irreversible AGE (6).  
 
Figure 6- The formation of AGE indicated by the fluorescence peak at 440 nm in 
hyperglycemic condition. 
After one week of incubation, the sample containing only BSA showed no emission at 440-
450 nm range incompliance with freshly prepared BSA with different glucose 
concentration. The presence of the glucose induced structural changes in the protein as 
established by CD analysis showing increased beta strands (table4) with the increase in the 
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glucose concentration. The alteration in the structure of the protein due to interaction with 
glucose (at a concentration > 1mg/ml) after 1 week of incubation may expose hydrophobic 
residues of the protein increasing fluorescence.  As the glucose forms hydrophobic 
interactions with the bovine serum albumin as shown by the docking studies (Figure 2), 
high concentration of the glucose leads to more such interactions thus exposing 
hydrophobic residues.  
 
Figure 7- The plot showing hydrophobic interaction of the glucose with the residues of the 
BSA. 
The structural changes due to these interactions caused the formation of the protein 
crosslink in the presence of the high concentration of the glucose resulting in the blue shift 
in the fluorescence peak towards 440nm. The fluorescent peak at 440 nm confirms the 
presence of pentosidine (21) and the crossline (the cross linked fluorescent AGEs) with 
BSA in hyperglycaemic condition. 
4.2 Structural change in BSA due to AGE formation- 
The serum albumin is the predominant protein present in the blood. Being the globular 
protein it has presence of the helices rather than beta strands as depicted in the ramachandran 
plot. 
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Figure 8- the 3D structure of the bovine serum albumin obtained from the protein data bank. 
 
 
Figure 9- Ramachandran plot of the bovine serum albumin 
The bovine serum albumin structure consists of 68 numbers of the helices and 67 turns but no 
beta strands as shown in the data depicted in Table 3 obtained from the Rasmol software.  
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Table 3- The types and number of the secondary structures present in the BSA 
Types of secondary structure in the BSA Number of secondary structures 
helices 68 
strands 0 
turns 67 
Thus in the native form the bovine serum albumin do not consists of the beta sheets as the 
secondary structures. Any change in the secondary structure present in the protein clearly 
alters the protein structure. 
Table 4- The ratio of secondary structures present after AGE formation- 
Ratio of secondary 
structures 
BSA BSA+1mg/ml 
glucose 
BSA+3mg/ml 
glucose 
Helix 37.2 38.2 33.3 
Beta 8.5 4.3 21.2 
Turn 22.1 24 17.6 
Random 32.2 32.2 27.9 
Total 100 100 100 
In comparison with the CD analysis of BSA alone after one week of incubation in PBS, the 
BSA in the in 1mg/ml of the glucose concentration showed slight decrease in beta sheets 
compensated by increase in turns. Overall, the percentage of secondary structures present in 
the BSA measured after one week of incubation showed almost no variation in normal 
glucose concentration (1mg/ml). The increase in the concentration of the glucose to 3mg/ml 
increased the percentage of the beta strands to 33.3 compared to the control with just 8.5, 
pointing to the significant structural changes in the hyperglycaemic condition as shown in the 
table4. 
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Figure 10- the secondary structures present in the BSA in different glucose concentration. 
Previous studies (23) have already confirmed that the presence of higher percentage of beta 
strands is the structural characteristic of advanced glycation end products (AGEs). 
4.3 The formation of the non-fluorescent AGEs in vitro- 
The three types of AGEs has been described i.e. non fluorescent cross-linking AGEs, 
fluorescent cross linking AGEs and non –cross linking non-fluorescent AGEs. The 
fluorescence emission spectra at the 440-450 nm range indicated towards the formation of the 
fluorescent cross linking AGEs. The m/z ratio of the peptides obtained from the electron 
spray ionization mass-spectrometry (ESI-MS) for the one week-incubated BSA in the 
hyperglycaemic condition (Table 5) confirmed the formation of the non-cross linking non-
fluorescent AGEs. One of the reversible intermediate for the formation of the AGEs by the 
amadori reagents is also detected at m/z ratio of the 553.64. 
Table 5- the non fluorescent AGE detection with the m/z ratio of the peptide- 
m/z ratio of peptide Product formed 
449.60 CML( carboxy methyl lysine ) 
553.64 Schiff  base/AP 
572.27 Pyrraline 
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Figure 11- The m/z ratio of the 553.64 and 572.27 is the presence of the Schiff base and 
pyrraline in the in vitro glycation model with the BSA. 
 
Figure 12- The peptide at m/z ratio of the 449.60 is the formation of the CML (carboxy 
methyl lysine). 
The 449.60 m/z ratio of the peptide indicates the formation of the CML (carboxy methyl 
lysine), one of the early AGEs formed after glycation in vivo. The pyrraline, a non-
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fluorescent AGE, was also formed as pointed by the m/z ratio of the 572.27 in the one week-
incubated BSA under hyperglycaemic conditions. 
The in vitro glycation model confirmed the formation of the both fluorescent and non 
fluorescent AGEs. The intensity of the 449.60 peak clearly indicates that one of the 
predominant AGEs formed is the CML (carboxy methyl lysine) among the non fluorescent 
non-cross linking AGEs. 
4.4 The effect of inhibitors on the formation of the AGEs- 
The AGEs lead to ROS generation, and the ROS generation accelerates gluco-oxidation 
which is one of the methods for the formation of the AGEs. To break this cycle of amplifying 
AGE formation, the antioxidant glutathione in the concentration of 2.5mg per ml was added. 
But contrary to predicted result, glutathione enhanced fluorescence intensity. This 
paradoxical result can be explained by the inability of in vitro environment to replenish 
reduced glutathione.  
 
Figure 13- The relative fluorescent intensity at 440nm with addition of antioxidants and 
chelator. 
 
Glutathione (GSH) donates electrons to reduce disulfide bridges to cysteines present in the 
protein and itself getting oxidized to glutathione disulfide (G-S-S-G). In the biological 
system, oxidized glutathione is reduced by NADPH so that the anti-oxidant property 
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continues. On the contrary, in vitro environment, the reduced glutathione was not replenished 
leading to a decrease in the GSH/G-S-S-G ratio. 
This in turn, results in oxidative stress inducing structural changes in the protein and 
accelerating the formation of AGEs. Thus, ROS generation and protein glycation form a 
vicious cycle that initiates, accelerates and maintains the patho- physiological mechanisms 
leading to diabetic complications.  From the docking study, the binding energy of the 
EDTA with the BSA was found to be -31.22 kcal/mol, lower than that of glucose with BSA 
(-35.40 kcal/mol). The preferential binding of the EDTA over glucose with BSA prevents 
binding of the glucose with subsequent reduction in glycation indicated by the fluorescent 
intensity close to fluorescence intensity of BSA alone. Since the binding residues on target 
glycated protein were found to be different, The EDTA probably acted as non-competitive 
inhibitor for the glucose to bind to BSA resulting in radical reduction in AGEs formation. 
At the same time, the combination of the glutathione, EDTA and ascorbic acid almost 
nullified the fluorescence at 440nm indicating that the binding of the EDTA stabilized the 
protein and the ascorbic acid antioxidant activity of ascorbic acid was complemented by the 
presence of the glutathione. 
4.5 Macrophage activation in high glucose – NBT test- 
The two main biological systems responsible for the ROS generation in vivo are the 
mitochondria and the NADPH oxidase (23).  
 
Figure 14- The macrophage activation for superoxide production in hyperglycemic condition. 
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The increase in glucose concentration increased the activity of NADPH oxidase and induced 
expression of iNOS causing more superoxide formation.  Macrophages are highly active with 
increased superoxide production in high glucose (4mg/ml).The superoxide production 
enhanced with the increase in the duration of the exposure of the macrophages to the high 
glucose concentration. The unregulated glucose concentration in diabetic conditions enhances 
the ROS production leading to the diabetic complications. 
4.6 Cell viability with the MTT assay- 
 
Figure 15- The MTT assay for the cell viability in high glucose. 
As per the MTT assay results (Figure 15), the viability of the cells reduced with the increase 
in the time of exposure to the high glucose environment. The diminished cell viability in 
response to high glucose was further verified by   trypan blue test. The high glucose induced 
ROS generation due to dysfunctional mitochondria validates the impaired activity of the 
dehydrogenase complex of the mitochondria responsible for the high ROS production. 
The MTT determines the metabolic state of the cell. The dehydrogenase of the mitochondrial 
enzyme complex reduces MTT to the formazan during normal metabolic activity of the cell 
representing cell viability. Under the influence of the high glucose concentration the 
dysfunctional mitochondria accelerates ROS generation. In the normal metabolic state, only 
complex 3 of the mitochondria is involved in the ROS generation. In the non haemostatic 
condition the complex 1, 2 and complex 3 enhances ROS production as a consequence of the 
mitochondrial dysfunction. The activity of the complex 1 and complex 2 is determined by the 
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MTT assay. The high glucose condition augments ROS generation above physiological limit 
that can lead to immediate cell death or enhance AGE formation.  
4.7 Types of ROS generated- 
The H2DCFDA dye detects the formation of overall oxygen free radicals (hydrogen 
peroxide, cytosolic super oxides, mitochondrial super oxides, hydroxy radicals etc).  
 
Figure 16- The graph indicates increase in intracellular ROS generation with time under 
hyperglycemic condition 
A substantial increase in all types of intracellular ROS was found with increasing glucose 
concentration from 2mg/ml to 4mg/ml. The results complemented the results obtained from 
NBT test. Thus high concentration of intracellular ROS being produced due to hyper activity 
of enzyme systems involved in superoxide production such as nitric oxide synthase and 
NADPH oxidase and mitochondrial superoxide production. The dye detects the formation of 
the both the intracellular and the extracellular reactive oxygen species produced by the 
mitochondria and the NADPH oxidase. The superoxides are the one of the predominant ROS 
generated in vivo. 
The NBT test only detects the superoxide production by the NADPH oxidase. Thus as 
indicated in the pie chart the predominant ROS generated is the superoxide free radicals 
among all the free radicals produced. The high glucose concentration increased the 
production of ROS with increase in incubation time. Thus all type of ROS generation 
pathways are hyper active under the influence of high glucose. 
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4.8 Intracellular ROS vs. Extracellular ROS- 
 
 
Figure 17- the graph representing greater intracellular ROS generation than extracellular in 
macrophages 
The high intracellular and extracellular ROS production is the main culprit behind 
inflammation, cell death.  
. 
 
Figure 18- the less extracellular ROS produced in macrophages in hyperglycemic condition. 
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The mitochondrion is the main source for the free radical production inside the cell causing 
protein oxidation, lipid peroxidation and other metabolic alterations. The enzyme system 
NADPH oxidase present on the plasma membrane of the phagocytic cells releases both the 
extracellular and intracellular superoxides.  The hyper activation of both the systems by 
various ligand and receptor interaction generates elevated levels of the ROS altering the 
structure and function of the biomolecules present inside the cell and the cell matrix. 
The graph points to that with the increase in the glucose concentration; the intracellular 
ROS production is also elevated by the macrophages. The highest fluorescent intensity 
obtained in the cells incubated with the 4mg/ml of the glucose in the media with respect to 
the control. 
Only few membrane bound enzyme systems are involved in the extracellular ROS 
generation such as NADPH oxidase. The increase in the glucose concentration in the media 
used for the culturing macrophages enhanced the formation of the extracellular ROS. The 
more intracellular ROS generated in comparison to the extracellular ROS shows that the 
mitochondria and various other systems are involved in the intracellular ROS production. 
The mitochondrion is the predominant source for the generation of the ROS. 
4.7 Comparing mitochondrial activity with the ROS generation- 
The high glucose inside the cell causes more glucose to get oxidized in the TCA cycle, 
pushing more electron donors (NADH and FADH2) into the electron transport chain. 
 
Figure 19- The graph representing comparative analysis of role of mitochondria in ROS 
generation. 
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As a result the voltage gradient across the mitochondrial membrane increases until a critical 
threshold is reached. At this point electron transfer inside complex 3 is blocked, causing the 
electrons to back up to co-enzyme Q, which donates the electrons one at a time to molecular 
oxygen, thereby generating superoxide. 
Based on in vitro studies it has been hypothesized that excess production of O2
-
 is via the 
premature collapse of the mitochondrial membrane potential so that electrons leakage from 
the complex1 to form superoxide and hydrogen peroxide rather than ATP. In high glucose at 
8
th
 and 16
th
 day significant collapse of the mitochondrial membrane potential observed with 
increase in ROS generation by the cell. 
4.8 The glycation of the human serum albumin – 
The formation of the in vitro AGEs has been established using BSA as in vitro model.  
 
Figure 20- Human Serum albumin (HSA) showing no fluorescence in the emission range of 
440-470nm 
 
Figure 21- HSA incubated with the glucose for one week showing fluorescence in the 
emission range of 440-470nm 
Based on the results obtained with the BSA incubated in hyperglycemic conditions for the 
one week forming both fluorescent and the non-fluorescent AGEs , the human serum albumin 
incubated with the 3mg/ml of the glucose after one week was added to the media of the 
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macrophages. The blue emission in the range of the 440-470 nm was observed under 
confocal microscope. The human serum albumin in the absence of the glucose shows no 
fluorescence as shown in the figure 20. The addition of 3mg/ml of the glucose increased the 
fluorescence at 440nm (the blue fluorescence) as depicted in the figure 21. 
 
 
 
Figure 22- HSA incubated with the glucose for 2weeks showing increased fluorescence in the 
emission range of 440-470nm 
 
The increase in the fluorescence with the increase in the incubation time was observed as 
shown in the figure22. The formation of the fluorescent AGEs has been established with the 
human serum albumin in the hyperglycaemic conditions. 
4.9 The formation of the intracellular AGEs in the macrophages- 
There is formation of the both intracellular and extracellular AGEs in the influence of the 
high glucose concentration. The amadori rearrangements and the auto-oxidation are the main 
mechanisms involved in the formation of the AGEs. In the cells both the pathways are active 
as the high influx of the glucose through glycolytic and polyol pathways forms intermediates 
such as glyceraldehydes-3-phosphate , dihydroxyacetone phosphate generating alpha 
dicarbonyl precursors involved in the formation of the advanced glycation end products.  
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Figure 23- The macrophages after one month of the culturing in low glucose media 
showed no formation of the intracellular AGEs. 
 
 
Figure 24- The macrophages after one month of the culturing in high glucose showed 
intracellular AGEs formation. 
The auto-oxidation of the glucose in the presence of the reactive oxygen species formed 
inside the cells under high glucose condition forms alpha dicarbonyl precursor as a 
consequence intracellular AGEs formation is being contributed by both the mechanisms.   
4.10 The interaction of the AGEs with the receptors present on the surface of 
macrophages- 
The macrophages express RAGE and scavenger receptor on their surface. 
 
Figure 25- The macrophages cultured for 1 month in 2mg/ml of the glucose concentration 
show very less ROS generation. 
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Figure 26- The increased ROS production due to addition of the extracellular AGEs in 
the media of the macrophages.  
 
The interaction of the formed AGEs with these receptors activates NADPH oxidase, 
increases expression of the NFκB, PKC isoforms and mitochondrial reactive oxygen 
generation.  
 
Figure 27- The increase in the fluorescence intensity at 523 nm with 3mg/ml of the glucose in 
the media 
 
 
Figure 28- The addition of the extracellular AGEs elevated ROS production compared to the 
2mg/ml. 
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The AGEs formed in the in vitro glycated human serum albumin with the 2mg/ml, 3mg/ml 
and 4mg/ml of the glucose concentration respectively was added to the macrophages growth 
media containing 2mg/ml, 3mg/ml and 4mg/ml of the glucose respectively. After one week 
of the incubation at 37ºc the samples were analyzed for the ROS generation. The 
macrophages are growing in the high glucose concentration from one month which definitely 
increased the expression of the RAGE on the surface of the macrophages. 
 
 
Figure 29- The fluorescence increase at 523nm in 8mg/ml of the glucose 
 
 
Figure 30- High ROS generation in the high glucose concentration of the 8mg/ml 
Thus extracellular AGEs added to the media interacted with these receptors, further 
increasing their expression and with the CD36 scavenger receptor activating ROS generating 
targets NADPH oxidase and the mitochondria. 
4.11 Effect of AGEs interaction with the receptors on oxidative stress and  
eveluating glutathione anti-oxidant property for the ROS generated in high 
glucose condition – 
The added AGEs in the media of the macrophages enhanced the ROS generation within 24hrs 
of incubation  as indicated by the increase in the fluorescent intensity at 523nm using 
H2CMDCFDA dye. 
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Figure 31- The glutathione inhibits ROS generation. 
Glutathione acts as scavenger for the reactive oxygen species generated in the human cells. 
The reduced form of the glutathione(GSH) gets oxidized to (G-S-S-G) in the process. The 2.5 
mg of the glutathione was  added and incubated for 24hrs. The reduced fluorescent intensity 
confirm that the GSH reacted with the extracellular ROS therefor decreasing the fluorescent 
intensity. 
 
Figure 32- the fluorescent intensity at 523 nm to check ROS generation with HSA and 
EDTA. 
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The reduced fluorescent intensity by addition of the EDTA decreased the overall ROS 
generated by the macrophages within 24hrs of the incubation. EDTA has preferential binding 
for both the proteins and the glycated proteins compared to the glucose. The binding of the 
EDTA with the protein helps protein to revert to the native form, thus high chances of the 
bound glucose being release and also preventing further binding with the glucose. The 
reduced intracellular AGEs concentration is having direct co-relation with the reduced ROS 
generation by the cells. 
The high glucose induced increased ROS production as confirmed by the NBT test. 
The greater ROS formation and also the high glucose conditions further lead to the formation 
of the intracellular AGEs by both the process of auto-oxidation of the glucose and the 
amadori rearrangements respectively. The intracellular AGEs formed and the interaction of 
the extracellular AGEs with the cells further exuberated ROS generation. 
4.13 Determining cyto-toxicity of the EDTA with the MTT assay- 
The 1.5mg/ml of the concentration used for the inhibition of the AGE formation is not 
cytotoxic to the cells. The viability of the cells is getting decreased with the addition of the 
extracellular AGEs to the macrophages. The higher the amount of the glycation and more the 
elevated glucose level causing significant decrease in the viability of the cells. As shown in 
the figure33. 
 
Figure 33- MTT assay to determine cyto toxicity of the EDTA. 
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The decrease in the viability is the indication towards the mitochondrial loss of the 
mitochondrial membrane potential. 
4.14 The interaction of the AGEs with the receptor present on the surface of the 
macrophages and role of EDTA – 
The interaction of the AGEs with the receptors present on the surface of the macrophages 
(RAGE and scavenger receptors) is significantly enhancing the ROS generation in the cells as 
compared to the high glucose induced cells.  
 
Figure 34- NBT assay for the ROS generation 
The addition of the EDTA is inhibiting both the intracellular and the extracellular formed 
AGEs. The reduction in the amount of the AGEs present is having direct consequences on the 
decreased ROS generation by the NADPH oxidase.  
The 1.5 mg/ml of the EDTA added is significantly reducing both the intracellular and the 
extracellular superoxides generated by the NADPH oxidase. The same concentration of the 
EDTA is effective against the high concentration of the AGEs formed in the case of the 
4mg/ml glucose used for the culturing of the macrophages. Thus the deprivation in the AGEs 
is definitely linked with the reduction in the reactive oxygen species. 
4.15 Comparisons of the MTT and NBT results with EDTA as inhibitor- 
The concentration of the EDTA used for the inhibitory studies is not cyto- toxic to the cells. 
The 1.5mg of the EDTA used is effective in inhibiting the intracellular AGEs formed due to 
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the culturing of the macrophages in the high glucose condition for one month. The same 
concentration is also effective for the inhibition of the extracellular AGEs added to the 
macrophage media therefore preventing the interaction of the extracellular AGEs with the 
receptors present on the macrophages.  
 
Figure 35- The comparative study of MTT and NBT assay 
The viability of the cells further decreased because of the generation of the more ROS due to 
the extracellular AGEs. The higher the amount of the formed AGEs the more is the activation 
of the pathways involved with the reactive oxygen species formation. The diabetic patients 
with highly unregulated glucose concentration are at high risk of the early diabetic 
complications. 
4.16 AGE formation in diabetic serum and inhibitory studies- 
The serum collected from 5 diabetic patients showed AGE formation with varied fluorescent 
intensities.  
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Figure 36- The diabetic serum based studies for the AGE formation. 
The highest fluorescent intensity observed in serum of sample2 having glucose concentration 
of 191mg/ml.The lowest fluorescent intensity observed in the sample4 serum with glucose 
concentration of 153mg/ml.The 1.5mg EDTA successfully inhibited AGE formation in the 
sample1 as indicated by decrease in fluorescent intensity as compared to fluorescent intensity 
in serum without inhibitor. With respect to the control serum (non-diabetic serum) having 
94mg/ml glucose concentration in the isolated serum the diabetic patient serum has high 
concentration of the AGEs present in the serum. The high the concentration of the circulating 
AGEs in the blood the more the patient is prone to renal failure and arthrosclerosis due to 
accumulation of these AGEs in the glomaerulus filtration unit of the nephron and in the blood 
vessels respectively. In the endothelial and macrophages these extracellular AGEs interact 
with the receptors present on the surface of these cells causing increase in the formation of 
the inflammatory cytokines further enhancing susceptibility to diabetic related complications. 
The intracellular AGEs cause lipid peroxidation, protein oxidation and changes in DNA 
structure. The structural and the functional changes in the biomolecules lead to the cell death.  
4.17 The role of the ascorbic acid and EDTA against the AGEs formed in the diabetic serum- 
The 2.5/ml mg of the ascorbic acid used as anti-oxidant increased the formation of the AGEs 
in the serum instead of inhibiting. The pro-oxidant activity of the ascorbic acid and also 
involvement of the SN2 nucleophilic addition reactions of the ascorbic acid with the proteins 
are the main reasons accelerating formation of the AGEs. 
42 
 
 
Figure 37- Inhibitory studies with the diabetic serum 
The pro-oxidant activity of the ascorbic acid is due to involvement in the fenton reaction 
generating hydroxy free radicals. The hydroxy free radicals further causing glucose auto-
oxidation thus AGE formation in the serum with the ascorbic acid.  
The addition of the ascorbic acid with the EDTA showed less increase in the fluorescent 
intensity as compared to the ascorbic acid alone in case of the sample 2 depicting 50% 
increase in the fluorescent intensity as shown in figure 37. The EDTA is definitely preventing 
amadori rearrangements and also chelating the transition metal present in the serum therefore 
inhibiting AGE formation. The auto-oxidation pathway is still active for the AGE formation 
due to pro-oxidant activity of the ascorbic acid thus there is net increase in the fluorescent 
intensity. The addition of the only EDTA is sufficient to inhibit the progression of the AGE 
formation in the serum. The EDTA is the effective inhibitor for the AGEs both in the in vitro 
model and also in the macrophages. 
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Chapter 5 
5.1 Summary 
 
The in vitro glycation model using bovine serum albumin (BSA) established the formation of 
the both fluorescent and non-fluorescent advanced glycation end products (AGEs) in the 
hyperglycaemic condition. The amount of AGEs formed increased with duration of the 
exposure to the hyperglycaemic condition. CD study confirmed the increase in beta sheets in 
secondary structure of glycated BSA that might prompt further progression AGEs formation.  
The high glucose triggered the ROS generation from mitochondria and the NADPH oxidase 
as verified from NBT and H2DCFDA assays. The cell under oxidative stress accelerated 
intracellular AGE formation via auto-oxidation pathway (20). The study concluded that 
protein glycation and ROS generation establishes a vicious cycle inside the macrophages that 
lead to progression in diabetic complications. 
The isolated diabetic serum showed substantial increase in the presence of the AGEs as 
compared to the control. These results are in compliance with the in vitro glycation model. 
The supplement of the ascorbic acid to the diabetic serum augmented AGE formation due to 
its pro-oxidant activity. This can be explained by formation of Schiff base with the proteins in 
the presence of ascorbic acid that further accelerates AGE formation by amadori 
rearrangements (38).    
5.2 Conclusion 
 
The current study made an in depth patho- physiological investigation of protein glycation 
both in vitro and in situ. The results confirmed that protein glycation and ROS generation 
complement to each other and establish a vicious cycle in diabetic patients. Thus, by targeting 
either pathway can pave the way to a novel therapeutic solution for diabetic complications as 
whole. 
5.3Future scope 
 
 The metacentric study involving more diabetic patients needed for further 
exploration.  
 The experimental study would be integrated effectively with in silico study to 
narrow down the process of pathway selection that leads to protein glycation and 
ROS generation. 
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 Clinical trial on use of ascorbic acid alone or in combination with glutathione and 
other anti-oxidants is needed to clarify the role of vitamin c in diabetic 
complications. 
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